Retatrutide
GIP, GLP-1 and glucagon receptor triagonist
Retatrutide is a synthetic peptide that acts as a triagonist at the GIP, GLP-1 and glucagon receptors. It is studied in metabolic research models.
Supplied lyophilised in a sterile glass vial. Purity is established by HPLC and identity confirmed by mass spectrometry, with both traces published on the batch certificate.
Research use only. Not for human or veterinary use. We cannot provide guidance relating to human consumption, including dosage, protocols or administration, under any circumstances. MYOGENX operates strictly as a research supplier.
£60.00
In UK stock
- SKU
- MGX-RET-20
- Batch
- MGX-2407-RET
- Dispatch
- Same day before 15:00, Mon to Fri
- Shipping
- Free over £75.00
Batch verified
MGX-2407-RET
Analysed by Janoshik Analytical. Published before this batch went on sale, and printed on the vial.
Read the certificateSpecification
The full record
Everything on the certificate, on the page. Nothing held back for after you have paid.
| Purity | 99.2% by HPLC |
|---|---|
| CAS number | 2381089-83-2 |
| Molecular weight | 4731.3 g/mol |
| Format | Lyophilised powder in a sterile glass vial |
| Appearance | White lyophilised solid |
| Storage | -20°C in a dry, dark, desiccated environment |
| Intended use | Laboratory research only. Not for human or veterinary use. |
Also in this category
